Lipoproteins and β-Cell Functions: From Basic to Clinical Data

par Lee, Dae Ho
Publié 2014

Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Databa...

par Lee, Dae Ho
Publié dans Diabetes Metab J (2015)

Second-generation anaplastic lymphoma kinase inhibitors: revolutionary or evolutionary?

par Lee, Dae Ho
Publié dans J Thorac Dis (2016)

Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era

par Lee, Dae Ho
Publié dans ESMO Open (2018)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease

par Lee, Dae Ho
Publié dans Endocrinol Metab (Seoul) (2020)

Update of early phase clinical trials in cancer immunotherapy

par Lee, Dae Ho
Publié dans BMB Rep (2021)

A personalized channel recommendation and scheduling system considering both section video clips and full video clips

par Lee, SeungGwan, Lee, DaeHo
Publié dans PLoS One (2018)

Osimertinib, the winner, but cannot yet take it all

par Yoon, Shinkyo, Kang, Jihoon, Lee, Dae Ho
Publié dans Ann Transl Med (2018)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors

par Kim, Na-Hyung, Yu, Taeyang, Lee, Dae Ho
Publié 2014

Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations

par Yoon, Shinkyo, Lee, Dae Ho, Kim, Sang-We
Publié dans Ann Transl Med (2017)

Comments on the trial of cisplatin and etoposide plus thoracic radiotherapy followed by nivolumab or placebo for locally advanced non-small cell lung cancer (RTOG 3505)

par Yoon, Shinkyo, Lee, Dae Ho, Kim, Sang-We
Publié dans J Thorac Dis (2017)

RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential

par Nam, Seungyoon, Kim, Jung Ho, Lee, Dae Ho
Publié dans Front Genet (2019)

Molecular Motor Proteins of the Kinesin Superfamily Proteins (KIFs): Structure, Cargo and Disease

par Seog, Dae-Hyun, Lee, Dae-Ho, Lee, Sang-Kyoung
Publié 2004

Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes...

par Cho, Eun-Hee, Han, Kyungdo, Kim, Bongseong, Lee, Dae Ho
Publié dans Medicine (Baltimore) (2020)

Gliclazide Does Not Fully Prevent 2-Deoxy-D-Ribose-Induced Oxidative Damage Because It Does Not Restore Glutathione Content in a Pancreatic β-Cell Line

par Koh, Gwanpyo, Kim, Min-Kyoung, Yang, Eun-Jin, Lee, Dae-Ho
Publié 2012

Metabolic actions of Rho-kinase in periphery and brain

par Huang, Hu, Lee, Dae-Ho, Zabolotny, Janice M, Kim, Young-Bum
Publié 2013

Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned

par Lee, Dae Ho, Srimuninnimit, Vichien, Cheng, Rebecca, Wang, Xin, Orlando, Mauro
Publié dans Cancer Res Treat (2015)

Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice

par Lee, Dae Ho, Huang, Hu, Choi, Kangduk, Mantzoros, Christos, Kim, Young-Bum
Publié 2012

Statins and All‐Cause Mortality in Patients Undergoing Hemodialysis

par Jung, Jaehun, Bae, Gi Hwan, Kang, Minsun, Kim, Soo Wan, Lee, Dae Ho
Publié dans J Am Heart Assoc (2020)

Antihypertensive effect of an enzymatic hydrolysate from Styela clava flesh tissue in type 2 diabetic patients with hypertension

par Ko, Seok-Chun, Jung, Won-Kyo, Lee, Seung-Hong, Lee, Dae Ho, Jeon, You-Jin
Publié dans Nutr Res Pract (2017)